Komori
Share Issuance and Disposal4881FunPep Company LimitedPharmaceuticals

Monthly Update on the Exercise Status of the 13th Stock Acquisition Rights with Exercise Price Adjustment Provisions

During March 2026, 39,300 of the 13th Stock Acquisition Rights were exercised, and 3,930,000 shares were delivered. As of month-end, 58,200 remained unexercised.

Worth reading
61In focus
Scored from 2 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
3930000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Monthly exercise status of stock acquisition rights with an exercise price adjustment clause

発行・処分する株式数

Number of shares delivered during the month: 3,930,000 shares (3,930,000 new shares and 0 transferred treasury shares)

発行済株式総数

Exercise ratio subject to exercise restrictions: 9.60% (3,930,000 shares delivered across all series / 40,916,700 listed shares as of the payment date for the issuance)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
The exercise prices during the month were ¥93, ¥92, ¥103 and ¥105. Details of the adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total issued: 97,500; exercised during the month: 39,300; unexercised at month-end: 58,200
Procedures under the Corporate Code of Conduct
As part of the status of compliance with exercise restrictions, the company reports compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters.
Most recent equity financing
13th Stock Acquisition Rights issued on 9 March 2026 (with exercise price adjustment provisions)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalMonthly exercise status of stock acquisition rights with an exercise price adjustment clause
Number of shares to be issued or disposed ofNumber of shares delivered during the month: 3,930,000 shares (3,930,000 new shares and 0 transferred treasury shares)
Dilution RateExercise ratio subject to exercise restrictions: 9.60% (3,930,000 shares delivered across all series / 40,916,700 listed shares as of the payment date for the issuance)
Total number of issued shares40,563,800 shares (as of the end of the month preceding the subject month) → Not disclosed
Exercise priceThe exercise prices during the month were ¥93, ¥92, ¥103 and ¥105. Details of the adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition RightsTotal issued: 97,500; exercised during the month: 39,300; unexercised at month-end: 58,200
Procedures under the Corporate Code of ConductAs part of the status of compliance with exercise restrictions, the company reports compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters.
Most recent equity financing13th Stock Acquisition Rights issued on 9 March 2026 (with exercise price adjustment provisions)
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status and compliance with exercise restrictions.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Monthly Update on the Exercise Status of the 13th Stock Acquisition Rights with Exercise Price Adjustment Provisions | FunPep Company Limited (4881) timely disclosure | Komori